Ter Laak Mariël P, Brakkee Jan H, Adan Roger A H, Hamers Frank P T, Gispen Willem Hendrik
Department of Medical Pharmacology, Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, Universiteitsweg 100, 3584 CG, Utrecht, The Netherlands.
Eur J Pharmacol. 2003 Feb 21;462(1-3):179-83. doi: 10.1016/s0014-2999(02)02945-x.
The neurotrophic and neuroprotective potential of the alpha-melanocyte-stimulating hormone (alpha-MSH) analog cyclo-[Ac-Nle(4),Asp(5),D-Phe(7),Lys(10)]alpha-MSH-(4-10) amide (melanotan-II), a potent melanocortin receptor agonist, was investigated. The sciatic nerve crush model was used as a paradigm to investigate the neurotrophic properties of melanotan-II. Melanotan-II significantly enhanced the recovery of sensory function following a crush lesion of the sciatic nerve in the rat at a dose of 20 microg kg(-1) per 48 h, s.c., but not at a dose of 2 or 50 microg kg(-1). In addition, we observed that melanotan-II also possesses neuroprotective properties, as it partially protected the nerve from a toxic neuropathy induced by cisplatin. Thus, the present data for the first time demonstrate the effectiveness of the potent alpha-MSH analog melanotan-II in nerve regeneration and neuroprotection.
对强效促黑素皮质素受体激动剂α-黑素细胞刺激素(α-MSH)类似物环[Ac-Nle(4),Asp(5),D-Phe(7),Lys(10)]α-MSH-(4-10)酰胺(美拉诺坦-II)的神经营养和神经保护潜力进行了研究。坐骨神经挤压模型被用作研究美拉诺坦-II神经营养特性的范例。美拉诺坦-II以每48小时20微克/千克的剂量皮下注射时,能显著促进大鼠坐骨神经挤压损伤后感觉功能的恢复,但2微克/千克或50微克/千克的剂量则无此效果。此外,我们观察到美拉诺坦-II还具有神经保护特性,因为它能部分保护神经免受顺铂诱导的毒性神经病变的影响。因此,目前的数据首次证明了强效α-MSH类似物美拉诺坦-II在神经再生和神经保护方面的有效性。